Sponsor:
Mayo Clinic
Code:
NCT05584449
Conditions
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18 - 39
Healthy Volunteers: Not accepted
Interventions
Counseling
Discussion
Informational Intervention
Medical Chart Review
Quality-of-Life Assessment
Brief summary:
Conditions
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT05584449
Start date
Jan 16, 2023
Status verified date
Jan, 2026
Completion date
Oct 18, 2027
Anticipated
Primary completion date
Oct 18, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 39
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Intervention Model
Single group
Primary purpose
Supportive Care
Arms
experimental: Supportive Care (group curriculum)
Interventions
Counseling
Discussion
Informational Intervention
Medical Chart Review
Quality-of-Life Assessment
Questionnaire Administration
Primary outcome measure
Locations
Mayo Clinic in Arizona
Recruiting
Scottsdale, Arizona, United States, 85259
Contacts
Principal Investigator:
Melody A. Griffith, MSW, LMSW
Sponsor
Mayo Clinic
Last update posted
Jan 30, 2026
Last verified
Jan, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-01-30.